Keratoacanthoma

Journal of the American Academy of Dermatology

Volumn 30, Issue 1, 1994, Pages 1-19

  Schwartz, Robert A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; KERATOACANTHOMA; MALIGNANT TRANSFORMATION; NOTE; PRECANCER; PRIORITY JOURNAL; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0027972681     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(94)70001-X     Document Type: Article

References (226)

1. The keratoacanthoma: a review
2. Squamous cell carcinoma
3. Morbid growths and tumours. 1. The “crateriform ulcer of the face,” a form of acute epithelial cancer
4. A peculiar form of cancer of the skin
5. Demonstrations at the clinical museum: the crateriform ulcer—microscopic examination
6. Kyste sébacé atypique
7. Verrucome avec adénite, à structure epithe-liomatiforme, curable par le 914
8. Molluscum sebaceum
9. Keratoacanthoma as a pathogenetic and clinico-histological problem, its 40th anniversary
10. Keratoacanthoma—a thirty-year retrospect
11. Tumor-like keratoses: report of a case
12. Spontaneous regression of keratoacanthoma
13. A case of multiple primary squamous-celled carcinomata of the skin in a young man, with spontaneous healing
14. Multiple primary, self-healing squamous cell carcinomas of the skin
15. Self-healing primary squamous cell carcinoma of the skin
16. Multiple primary spontaneous-healing squamous-cell carcinomata of the skin
17. A histologic chronology of the clinical course of the keratocarcinoma (so-called keratoacanthoma). Mt
18. A case of peculiar generalized epithelial tumours of the skin
19. Generalized eruptive keratoacanthoma of Grzybowski
20. Das Keratoakanthoma centrifugum—eine besondere Varietät des Keratoakanthoms
21. Controversies in Dermatology. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. With responses by Grant-Kels JM, From L, Reed RJ, et al
22. Diagnostic problem of keratoacanthoma
23. Keratoacanthoma: a clinical study
24. Skin tumours in white South Africans
25. Skin tumours in white South Africans
26. Skin tumours in white South Africans
27. Skin tumours in white South Africans
28. Skin tumours in white South Africans
29. Solitary keratoacanthoma of the nipple in a male: case report
30. Skin cancer in Africa
31. Keratoacanthoma in a Bantu child
32. Keratoacanthoma
33. Keratoacanthoma in Kauai, Hawaii: the first documented incidence in a defined population
34. Multiple self-healing squamous epithelioma
35. Multiple self-healing epithelioma of Ferguson Smith type: report of a case of unilateral distribution
36. The etiology of keratoacanthoma
37. Eruptive keratoakanthome
38. Eruptive Keratoakanthome Typ Grzybowski und Ektropium: ein therapeutisches Problem
39. Multiple keratoacanthomas: a case study of the eruptive type with observations on pathogenesis
40. The role of the hair follicle in the origin and evolution of some cutaneous neoplasms of man and experimental animals
41. Keratoacanthoma dyskeratoticum and segregans
42. Keratoacanthoma centrifugum marginatum versus low-grade squamous cell carcinoma
43. Brief review of keratoacanthomas and description of keratoacanthoma centrifugum marginatum, another variety of keratoacanthoma
44. Multinodular keratoacanthoma
45. Ein Beitrag zur nosologischen Stellung des Keratoakanthoma centrifugum
46. Queratoacanthoma centrifugo de Miedzinski y Kozaldewicz
47. Keratoacanthoma centrifugum marginatum
48. Squamous cell pseudoepithelioma (keratoacanthoma): a new clinical variety, gigantic, multiple, and localized
49. Massive or giant keratoacanthoma
50. Giant keratoacanthoma of the inner surface of the prepuce
51. Giant keratoacanthoma of the nose
52. Subungual keratoacanthoma: possible relationship to exposure to steel wool
53. Subungual keratoacanthoma in the hand
54. Keratoacanthoma with osteolysis (a case report with an isolated interdigital lesion)
55. Solitary intraoral keratoacanthoma
56. Recurrent keratoacanthoma of the lip
57. Intra-oral keratoacanthoma: an eruptive variant and review of the literature
58. Solitary keratoacanthoma of the conjunctiva
59. Keratoacanthoma: mucous membranes as the site of its localization
60. Solitary keratoacanthoma of the nasal vestibule
61. Multiple cutaneous and conjunctival keratoacanthomas
62. Multiple keratoacanthomas on the mons pubis and labia majora
63. Development of more keratoacanthomas following skin testing with nitrogen mustard in a patient with the multiple keratoacanthoma syndrome
64. Multiple keratoacanthoma in a female infant
65. Multiple keratoacanthomata: a unique case and review of the current classification
66. Multiple keratoacanthomas on upper extremities
67. Multiple keratoacanthomas: a case report with evidence of regression with thymic hormone
68. Familial primary self-healing squamous epithelioma of the skin (Ferguson Smith type)
69. Multiple keratoacanthomata: a report of two cases
70. Mollusca pseudocarcinomatosa: discussion of a case of the Ferguson Smith type of unilateral distribution
71. Multiple keratoacanthomas with peculiar manifestations and course
72. Multiple persistent keratoacanthomas
73. Multiple keratoacanthomas
74. Multiple keratoacanthoma
75. Grzybowski's eruptive keratoacanthoma
76. Eruptive keratoacanthoma en plaque in an immunosuppressed patient
77. Eruptive keratoacanthoma with an internal malignant neoplasm
78. Multiple, primary, self-healing prickle-cell epithelioma of the skin
79. Grzybowski's generalized eruptive keratoacanthoma
80. Carcinoma of the larynx in two patients with keratoacanthoma
81. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acathomata of the face
82. Multiple sebaceous tumors
83. The Torre syndrome with gastrointestinal polyposis
84. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms
85. The Muir-Torre (Torre's) syndrome: the significance of a solitary sebaceous tumor
86. Torre's syndrome: report of two cases and review of the literature
87. Muir-Torre syndrome: histologic spectrum of sebaceous proliferations
88. Kérato-acanthomes multiples et carcinomes viscéraux; syndrome de Torre
89. Keratoacanthoma and multiple carcinomas
90. Aggressive keratoacanthoma and internal malignant neoplasm
91. Kérato-acanthomes multiples éruptifs révélateurs d’un lymphome
92. Radiation therapy of keratoacanthoma
93. Ultraviolet light—induced carcinogenesis
94. Keratoacanthoma in xeroderma pigmentosum
95. Florid cutaneous papillomatosis
96. Florid cutaneous papillomatosis, malignant acanthosis nigricans, and pulmonary squamous cell carcinoma
97. Keratoacanthoma arising in an organoid nevus during childhood: case report and literature review
98. Life history of organoid nevi: special reference to nevus sebaceus of Jadassohn
99. Keratoacanthoma arising within organoid naevi
100. Pseudoepitheliomatous reaction (pseudorecidive) following radiation therapy of epitheliomata
101. Multiple keratoacanthomas after megavoltage radiation therapy
102. Self-healing pseudocancers of the skin
103. Sudden appearance of multiple keratoacanthomas three weeks after thermal burns
104. Keratoacanthoma as a complication of arterial puncture for blood gases
105. Keratoacanthoma in a smallpox vaccination site
106. Keratoacanthomas arising in hypertrophic lichen planus
107. Multiple keratoacanthoma in discoid lupus erythematosus
108. Giant keratoacanthoma complicating dermatitis
109. Multiple keratoacanthomas and squamous cell carcinomas occurring at psoriatic treatment sites
110. Keratoacanthomata associated with psoriasis
111. Multiple keratoacanthomas: relation to Jamarsan therapy for pemphigus foliaceus
112. Multiple keratoacanthomas and junctional epidermolysis bullosa: a therapeutic conundrum
113. Keratoacanthoma (mol-luscum sebaceum)
114. Unusual reaction to application of podophyllum resin
115. Premalignant and malignant skin tumours in immunosuppressed patients
116. Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin
117. Keratoacanthoma ensuing from bone marrow transplantation for chronic myeloid leukemia
118. Keratoacanth-omes multiples sous ciclosporine
119. No difference in skin cancer incidence with or without cyclosporine: a 5-year perspective
120. The histogenesis of experimental molluscum sebaceum
121. Experimental study of the pathogenesis of carcinoma
122. A comparative morphological study of kerato-acanthoma of man and similar experimentally produced lesions in the rabbit
123. The experimental production of keratoacanthomas in the hamster and the mouse
124. The role of the mouse hair cycle in epidermal carcinogenesis
125. An experimental analysis of the “hair cycle effect” in mouse skin carcinogenesis
126. ras activation in human tumors and in animal model systems
127. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma
128. p53 protein expression in benign and malignant skin tumours
129. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer
130. Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapy
131. Skin tumors in the European PUVA study
132. Electron microscopy of viruslike particles in a keratoacanthoma
133. Intranuclear particles in keratoacanthoma: possible association with malignant degeneration
134. Keratoacanthoma
135. Demonstration of human papillomavirus DNA in two keratoacanthomas
136. Human papillomavirus 25—related DNA in solitary keratoacanthoma
137. Human papillomavirus associated with keratoacanthomas in Australian patients
138. Keratoacanthomas: human papillomavirus associated?
139. Rogowiak kolczastoko-mórkowy—keratoacanthoma (molluscum sebaceum, molluscum pseudocarcinomatosurn). Studium patologiczno-kliniczne
140. Tripolar mitosis in a keratoacanthoma
141. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma
142. Immunohistochemical demonstration of actinically damaged elastic fibers in keratoacanthomas: an aid in diagnosis
143. Actinic keratoacanthoma: speculations on the nature of the lesion and the role of cellular immunity in its evolution
144. Aggressive histologic features of keratoacanthoma
145. Perioral keratoacanthoma with extensive perineural invasion and intravenous growth
146. Intravascular spread of keratoacanthoma: an alarming but benign phenomenon
147. Atypical sweat duct hyperplasia accompanying keratoacanthoma
148. Electron microscopic study of keratoacanthoma
149. Analysis of histopathological and electron microscopic determinants of keratoacanthoma and squamous cell carcinoma
150. Quantitatively evaluated ultrastructurat findings can add to the differential diagnosis between keratoacanthoma and well differentiated squamous cell carcinoma
151. An ultrastructure study of the experimental keratoacanthoma
152. Epidermal antigens in experimental keratoacanthoma and squamous cell carcinoma
153. DNA image cytometry of keratoacanthoma and squamous cell carcinoma
154. DNA cytophotometry as a method for differentiation between keratoacanthoma and spinocel-lular carcinoma
155. Multiparameter DNA flow cytometry of keratoacanthoma
156. A flow cytometric study of the DNA content from paraffin-embedded samples of keratoacanthoma and squamous cell carcinoma
157. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma
158. Selected precancerous skin and mucocutaneous lesions
159. A technique of biopsy recommended for keratoacanthomas
160. Histopathologic considerations in the management of skin cancer
161. Blastomycosis in otolaryngology: review of a large series
162. Keratoacanthoma and squamous cell carcinoma of the skin: immunohis-tochemical localization of involucrin and keratin proteins
163. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma
164. Quantitation of S100 protein-positive cells in inflamed and non-indurated keratoacanthoma and squamous cell carcinoma
165. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin
166. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma
167. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma
168. Cell-surface carbohydrates in proliferative epidermal lesions: distribution of A, B, and H blood group antigens in benign and malignant lesions
169. Transforming growth factor α expression helps to distinguish keratoacanthomas from squamous cell carcinomas
170. Basal cell carcinoma associated with keratoacanthoma
171. Keratoacanthoma within a superficial spreading malignant melanoma in situ
172. Verrucous carcinoma
173. Giant condyloma acuminatum of Buschke and Lowenstein
174. Chromoblastomycosis can mimic keratoacanthoma
175. Condyloma latum mimicking keratoacanthoma in patient with secondary syphilis
176. Histoid lepromas of lepromatous leprosy
177. Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: clinical and histologic aspects
178. The spontaneous regression of keratoacanthoma in man
179. Aggressive keratoacanthoma of the eyelid: “malignant” keratoacanthoma or squamous cell carcinoma
180. Multiple keratoacanthomas: association with deficient cell mediated immunity
181. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours
182. Detection of an antisquamous antibody in multiple keratoacanthoma
183. Identification of CD16/ NKH-1+ natural killer cells and their relevance to cutaneous immunity
184. Hypocom-plementemia in keratoacanthoma
185. Keratoacanthoma associated with leprosy
186. Incidence of skin carcinoma after renal transplantation
187. Immunological findings during treatment of multiple keratoacanthoma with etretinate
188. Analysis of lymphocyte subpopulations using monoclonal antibodies in a case of keratoacanthomas
189. Non-immunological regression of dimethylbenz(A) anthracene-induced experimental keratoacanthomas in the rabbit
190. Immune response to human keratoacanthoma
191. Non-immunologic enhancement and regression of self-healing squamous cell carcinoma (keratoacanthoma)—ground substance and inflammation
192. Surgical treatment for aggressive giant keratoacanthoma of the face
193. Ocena chirurgicznego leczenia rogowiaka kolczystokomórkowego
194. Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery)
195. Treatment of keratoacanthomas with curettage
196. Extirpation of keratoacanthomas by blunt dissection
197. Evaluation of curettage and electrodesiccation in treatment of keratoacanthoma
198. Treatment of aggressive keratoacanthomas by radiotherapy
199. Radiation therapy of giant aggressive keratoacanthomas
200. Argon laser treatment of small keratoacanthomas in difficult locations
201. Cryosurgery
202. The use of podophyllin in the treatment of keratoacanthoma
203. Tumors of the skin-II. Keratoacanthoma: local effect of 5-fluorouracil
204. Treatment of keratoacanthomas with intralesional fiuorouracil
205. Zastosowanie maści Efudix w leczeniu rogowiaka kolczystokomórkowego (keratoacanthoma). I. Kliniczna ocena wyników leczenia
206. Zastosowanie maści Efudix w leczeniu rogowiaka kolczystokomórkowego (keratoacanthoma). II. Obserwacje histologiczne w przebiegu leczenia
207. Large keratoacanthomas in difficult locations treated with intralesional 5-fiuorouracil
208. Treatment of keratoacanthoma with intralesional bleomycin
209. A case of squamous cell carcinoma treated with intralesional injection of oil bleomycin
210. Treatment of keratoacanthomas with intralesional methotrexate
211. Multiple keratoacanthomata: response of a case to systemic chemotherapy
212. Keratoacanthoma treated with methotrexate
213. Transfer factor II: results of therapy
214. Multiple persistent keratoacanthomas: treatment with oral etretinate
215. Multiple keratoacanthomas treated with oral retinoids
216. Intradermal triamcinolone therapy of keratoacanthomas
217. Large keratoacanthomas treated with intralesional interferon alfa-2a
218. Dermatologic pseudobenignities